[1]陈远征,李 梁,杨青文,等.口服普萘洛尔不同给药次数治疗婴幼儿血管瘤的前瞻性随机对照研究[J].中国美容医学,2023,(8):103-106.[doi:10.15909/j.cnki.cn61-1347/r.005855]
　HEN Yuanzheng,LI Liang,YANG Qingwen,et al.A Prospective Randomized Controlled Study on Different Administration Frequency of Oral Propranolol in Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2023,(8):103-106.[doi:10.15909/j.cnki.cn61-1347/r.005855]
点击复制

口服普萘洛尔不同给药次数治疗婴幼儿血管瘤的前瞻性随机对照研究()
分享到：

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2023年8期
页码:
103-106
栏目:
出版日期:
2023-08-10

文章信息/Info

Title:
A Prospective Randomized Controlled Study on Different Administration Frequency of Oral Propranolol in Infantile Hemangiomas
文章编号:
1008-6455（2023）08-0103-04
作者:
陈远征1; 2; 李 梁2; 3; 杨青文2; 3; 陈福泰2; 3; 白 南4
(1.应急管理部应急总医院烧伤整形科 北京 100028 ;2.临沂市人民医院烧伤整形科 山东 临沂 276000 ;3.潍坊医学院临床 医学院烧伤外科 山东 潍坊 261053 ;4.临沂市人民医院美容整形科 山东 临沂 276000 )
Author(s):
HEN Yuanzheng12; LI Liang23; YANG Qingwen23; CHEN Futai23; BAI Nan4
(1.Department of Burns and Plastic Surgery,Emergency General Hospital of the Ministry of Emergency Management,Beijing 100028,China; 2.Department of Burns and Plastic Surgery,Linyi Peoples Hospital,Linyi 276000,Shandong,China; 3.Department of Burn Surgery,Weifang Clinical Medical College,Weifang Medical University,Weifang 261053,Shandong,China; 4.Department of Plastic and Aesthetic Surgery,Linyi Peoples Hospital,Linyi 276000,Shandong,China)
关键词:
婴幼儿; 血管瘤; 普萘洛尔; 服药次数
Keywords:
infantile;  hemangiomas ;  propranolol;  administration frequency
分类号:
R732.2
DOI:
10.15909/j.cnki.cn61-1347/r.005855
文献标志码:
A
摘要:
目的：比较普萘洛尔每日相同剂量不同给药频次治疗婴幼儿血管瘤的疗效，为临床治疗提供安全方便有效的给药次 数。方法：将2016年10月-2017年2月就诊于临沂市人民医院且符合入选标准的37例婴幼儿血管瘤患儿进行口服普萘洛尔治 疗，每日剂量2 mg/kg，根据给药次数的不同，采用随机数字表法分为A、B两组。A组19例，每日给药2次；B组18例，每日 给药3次。两组时间间隔均为8 h。记录治疗过程中不良反应发生情况、有效病例和治愈病例。6个月时对两组有效率、治愈 率及不良反应发生率进行比较。结果：37例婴幼儿血管瘤患儿在口服普萘洛尔后1周内，可见瘤体张力下降，颜色变淡。 治疗6个月时，A组19例患儿疗效评价Ⅰ级（差）1例，Ⅱ级（中）0例，Ⅲ级（好）4例，Ⅳ级（优）14例，有效率94.7% （18/19），治愈率73.7%（14/19）；不良反应发生率10.5%（2/19）。B组18例患儿疗效评价Ⅰ级（差）0例，Ⅱ级（中）0 例，Ⅲ级（好）4例，Ⅳ级（优）13例，因不良反应改变治疗剂量1例，有效率94.4%（17/18），治愈率72.2%（13/18）；不 良反应发生率11.1%（2/18）。6个月时两组有效率、治愈率、不良反应发生率比较差异无统计学意义（P＞0.05）。结论： 口服普萘洛尔每日2 mg/kg的剂量分2次给药与3次给药均安全、有效。推荐用药次数为每日2次。
Abstract:
Objective To study the efficacy of different administration frequencies of the same dose propranolol for infant hemangiomas , so as to provide safe, convenient and effective method. Methods From October 2016 to February 2017 ， there were 37 infants in accordance with the inclusion criteria,who were treated with propranolol at a dose of 2 mg/kg per day. According to the diff erent administration frequencies, they were randomly divided into A and B groups. Group A, 19 cases,a BID dosing; Group B, 18 cases, a TID dosing. The administration interval was eight hours . The eff ective rate, cure rate and adverse effect rate were compared at six months after treatment. Results 37 cases of infantile hemangiomas were treated. Primary effi cacy was assessed at one week after treatment. The tumors were smaller. The color changed from bright red to purplish red. At 6 months after treatment ,the curative eff ects were evaluated as follows: The treatment group A (19 cases): grade I (poor) 1 case, grade Ⅱ (fair) 0 case, grade Ⅲ (good) 4 cases, grade Ⅳ (excellent) 14 cases. The effective rate was 94.7 %(18/19).The cure rate was 73.7%(14/19). The incidence of adverse reactions was 10.5%(2/19).The treatment group B(18 cases): grade I (poor) 0 case, grade Ⅱ (fair) 0 case, grade Ⅲ (good) 4 cases, grade Ⅳ (excellent) 13 cases. The eff ective rate was 94.4 %(17/18).The cure rate was 72.2%(13/18). The incidence of adverse reactions was 11.1%(2/18).The eff ective rate and the cure rate were not statistically signifi cant(P ＞0.05).The incidence of adverse eff ects was not statistically signifi cant(P ＞0.05). Conclusion The administration frequencies of oral propranolol at 2mg/kg/d in infantile hemangiomas both 3 times per day and 2 times per day are safe and eff ective. The administration frequency of 2 times per day is recommended.

相似文献/References:

[1]杨 竞,张 晶,黄惠珍,等. 调Q1 064nm激光和调Q755nm激光治疗婴幼儿太田痣对比研究[J].中国美容医学,2019,(01):70.
　YANG Jing,ZHANG Jing,HUANG Hui-zhen,et al. Comparative Study on Q1 064nm Laser and Q755nm Laser Treatment of Infant Taitian Nevus of Ota[J].Medical Aesthetics and Beauty,2019,(8):70.
[2]姚天华,Krishna Regmi,杜婧婷,等. Bax在普萘洛尔诱导人血管瘤内皮细胞凋亡中的作用[J].中国美容医学,2019,(01):100.
　YAO Tian-hua,KRISHNA Regmi,DU Jing-ting,et al. The Effect of Bax on Propranolo Induced Hemangioma Endothelial Cell Apoptosis[J].Medical Aesthetics and Beauty,2019,(8):100.
[3]汪城河,苏晓灵,苏振民,等. 激光治疗婴幼儿浅表性血管瘤的疗效及并发症分析[J].中国美容医学,2019,(02):56.
　WANG Cheng-he,SU Xiao-ling,SU Zhen-min,et al. Clinical Analysis of the Effect and Complication of Laser Therapy for InfantileSuperficial Hemangioma[J].Medical Aesthetics and Beauty,2019,(8):56.
[4]谭红梅 吴 炜赵居艳 综述,张佩莲 审校. 婴幼儿血管瘤治疗进展[J].中国美容医学,2019,(05):163.
　TAN Hong-mei,WU Wei,ZHAO Ju-yan,et al. Progress in the Treatment of Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2019,(8):163.
[5] 何洛芸,韦妮波,马 瑗,等. Cynergy双波长激光联合马来酸噻吗洛尔治疗婴儿浅表性血管瘤疗效评价[J].中国美容医学,2021,(1):49.
　 HE Luo-yun,WEI Ni-bo,MA Yuan,et al.Efficacy Evaluation of Cynergy Dual-wavelength Laser Combined with TimololMaleate in the Treatment of Superficial Infantile Hemangioma[J].Medical Aesthetics and Beauty,2021,(8):49.
[6] 李雪丽,孙小云,尤加锐,等. Cynergy双波长激光联合普萘洛尔治疗婴幼儿浅表性血管瘤[J].中国美容医学,2021,(1):61.
　 LI Xue-li,SUN Xiao-yun,YOU Jia-rui,et al. Analysis of Therapeutic Effect of Cynergy Dual-wavelength Dye Laser Combinedwith Propranolol on Superficial Infantile Hemangioma[J].Medical Aesthetics and Beauty,2021,(8):61.
[7] 陈玉卿,章 恒,庄洁莲,等. 耳矫治器无创矫正先天性耳廓形态畸形疗效观察[J].中国美容医学,2021,(8):45.
　 CHEN Yu-qing,ZHANG Heng,ZHUANG Jie-lian,et al. Effect of Non-invasive Correction of Congenital Auricle Deformity with Ear Appliance[J].Medical Aesthetics and Beauty,2021,(8):45.
[8] 陈 红,李 媚,王利娜,等. 口服普萘洛尔联合Nd:YAG激光治疗婴幼儿血管瘤的美容效果分析[J].中国美容医学,2021,(10):89.
　 CHEN Hong,LI Mei,WANG Li-na,et al. Cosmetic Effect of Oral Propranolol Combined with Nd:YAG Laser in the Treatmentof Infantile Hemangioma[J].Medical Aesthetics and Beauty,2021,(8):89.
[9]钱 革,郭 武,吴邓婷,等.0.5%马来酸噻吗洛尔滴眼液局部封包联合持续加压法治疗婴儿血管瘤疗效评价[J].中国美容医学,2022,(3):25.
　QIAN Ge,GUO Wu,WU Dengting,et al.Safety and Efficacy of Occlusion Therapy Combined with Continuous Compression of Timolol Maleate 0.5% Eye Drops for Deep or Mixed Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2022,(8):25.
[10]付 欢,田晓娟,龚烨萱.家属参与“合作式”护理模式对手术治疗血管瘤患儿术后恢复的影响[J].中国美容医学,2022,(7):168.
　FU Huan,TIAN Xiaojuan,GONG Yexuan.Effect of Family Members’ Participation in "Cooperative" Nursing Model on Postoperative Recovery of Children with Hemangioma Treated by Surgery?/html>[J].Medical Aesthetics and Beauty,2022,(8):168.
[11]曹 阳,张雪英,张 彪. 脉冲染料激光治疗婴幼儿面部血管性疾病近期疗效观察[J].中国美容医学,2018,(03):69.
　CAO Yang,ZHANG Xue-ying,ZHANG Biao. Application of PDL in the Treatment of Facial Vascular Diseases in Infants[J].Medical Aesthetics and Beauty,2018,(8):69.
[12]尹轩羽,罗 滔,谭 军,等. 脉冲染料激光联合外用噻吗洛尔滴眼液治疗婴幼儿表浅型血管瘤疗效分析[J].中国美容医学,2019,(11):57.
　YIN Xuan-yu,LUO Tao,TAN Jun,et al. Effect of Pulsed Dye Paser Combined with Timolol Eye Drops on Superficial Hemangioma in Infants[J].Medical Aesthetics and Beauty,2019,(8):57.
[13]陈业莉,王 燕. 脉冲染料激光联合马来酸噻吗洛尔滴眼液外敷治疗婴幼儿血管瘤[J].中国美容医学,2020,(3):45.
　CHEN Ye-li,WANG Yan. Clinical Observation of 595 nm Pulsed Dye Laser Combined with 0.5% Timol MaleateEye Drops in the Treatment of Infantile Hemangioma[J].Medical Aesthetics and Beauty,2020,(8):45.

更新日期/Last Update: 2023-08-31